VIRTUAL REGISTRATION: 50th Annual Psychopharmacology Conference

Boston, MA US
October 16, 2026 to October 18, 2026

 

We invite you to join us Virtually for our 50th Annual Psychopharmacology conference! 

 

NOTE: Thursday ticketed events, and Friday and Saturday evening seminars are NOT included in the virtual registration option. These sessions will NOT be live-streamed.


Engage with Experts.
Elevate Results.
Enhance your Practice.


Please Note: The conference will be held in Eastern (EDT)

Celebrating 50 Years of Advancing Psychiatric Medicine

We invite you to attend the 50th Annual Psychopharmacology Conference virtually! This conference marks a meaningful milestone in the evolution of psychiatric education and care.

For five decades, this event has brought together leading experts and dedicated clinicians to advance the understanding and treatment of mental health conditions. In 2026, we reflect on that legacy—and look ahead to the next chapter.


What You Can Expect

This year’s program continues our commitment to clinical depth, scientific rigor, and practical application. Topics include:

  • Depression, Bipolar Disorder, and Anxiety

  • Psychosis and OCD

  • ADHD and PTSD

  • Substance Use Disorders

  • Integrative Approaches and Pharmacologic Innovations

Every session is designed to help you stay current on emerging research, examine evolving standards of care, and apply evidence-based strategies to complex clinical situations.

You will receive email communication (to the email registered to your MGH Psychiatry Academy account) as we get closer to the conference date with details on the Zoom instructions and attending virtually.


Pricing

MDs/Doctoral-Level Professionals

Super Early Bird Registration (on or before May 15, 2026): $830.00

Early Bird Registration (on or before August 15, 2026): $950.00

Regular Registration (after August 15, 2026): $1085.00

 

Other Professionals or Trainees

Super Early Bird Registration (on or before May 15, 2026): $675.00

Early Bird Registration (on or before August 15, 2026): $750.00

Regular Registration (after August 15, 2026): $850.00


Live Registration: 

The conference occurs live at the Westin Copley Place in Boston. For more information about in-person attendance and the venue, please visit our live registration page: 

Psychopharmacology 2026: Live Registration - Click Here


E-Syllabus 

We provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference. 


Cancellation Policy

 No refunds will be issued for refund requests. Payments made may not be applied to future conferences or other educational activities. There are no exceptions to these policies.


Massachusetts General Hospital Psychiatry Update & Board Preparation, 4th Edition

Board certification and recertification exams are critical career moments. That is why you should rely on the Massachusetts General Hospital Psychiatry Update & Board Preparation, Fourth Edition. It puts our 80+ years of clinical experience at your fingertips to help you prepare for your exam.

Purchase a print copy of our Board Preparation book here!
 

image


MOC Self-Assessment Module: Psychopharmacology

As part of recertification requirements, physicians must participate in Maintenance of Certification Program (MOC) activities like this one to cultivate a focus on lifelong learning and competency throughout one’s profession. This module helps you hone in on clinical and practice management skills that are central to quality patient care and improved outcomes for patients.

Register here!

Target Audience

This program is intended for psychiatrists, psychologists, general and family practice physicians, psychiatric nurses, physician assistants, nurse practitioners, and social workers.

Learning Objectives

By the end of this program, participants will be able to:

  • Identify rational, evidence-based pharmacologic and non-pharmacologic therapies for patients with unipolar, bipolar, treatment-resistant, and post-partum depression.

  • Compare the neurobiology and evidence-based treatment approaches to addiction, anxiety, schizophrenia, and mood disorders.

  • Review the course and treatment of psychiatric disorders during pregnancy and menopause.

  • Analyze drug interactions and the pharmacotherapy of adult ADHD and geriatric disorders.

  • Apply newer strategies in the treatment of chemical abuse/dependence.

  • Analyze evidence-based treatment for psychiatric illness.

  • Assess the most recent state-of-the-art treatment alternatives.

  • Assess new therapies and what is on the horizon.

  • Analyze the use of CBT-based techniques.


Accreditation

Please Check Back Soon for Accreditation Information.


Course summary
Registration opens: 
10/07/2025
Course closes: 
12/31/2026
Event starts: 
10/16/2026 - 8:00am EDT
Event ends: 
10/18/2026 - 4:45pm EDT
Cost:
$830.00
Rating: 
0

50th ANNUAL PSYCHOPHARMACOLOGY

OCTOBER 16-18, 2026
WESTIN COPLEY PLACE

BOSTON

FRIDAY, OCTOBER 16, 2026

8:00 – 8:10 AM            Welcoming Remarks & Introduction

Maurizio Fava, MD & Jerrold F. Rosenbaum, MD

MODULE TOPIC – MOOD DISORDERS

8:10 – 8:55 AM            Bipolar Depression

Andrew A. Nierenberg, MD

8:55 – 9:40 AM            Bipolar Long-Term Management

Roy Perlis, MD

9:40 – 9:55 AM            Break

9:55 – 10:40 AM          Treatment Resistant Depression

Maurizio Fava, MD

10:40 – 11:20 AM      Panel Discussion

Moderator: Jerrold F. Rosenbaum, MD

Panelists: Andrew A. Nierenberg, MD, Roy Perlis, MD, Maurizio Fava, MD

11:20 – 12:20 PM        Lunch Break

MODULE TOPIC – ANXIETY/PTSD

12:20 – 1:05 PM          PTSD & Insomnia

Amit Chopra, MBBS, DFAPA

1:05 – 1:50 PM            Anxiety Disorders and Treatments

Jerrold F. Rosenbaum, MD

1:50 – 2:30 PM            Panel Discussion

Moderator: Lee Cohen, MD

Panelists: Amit Chopra, MBBS, DFAPA, Jonah Cohen, PhD, Jerrold F. Rosenbaum, MD

2:30 – 2:45 PM            Break

MODULE TOPIC – WOMEN’S HEALTH

2:45 – 3:30 PM            Course and Treatment of Mood and Anxiety Disorders During Pregnancy

Lee S. Cohen, MD

3:30 – 4:15 PM            Postpartum Mood and Anxiety Disorders

Marlene P. Freeman, MD

4:15 – 4:55 PM            Panel Discussion

Moderator: Lee S. Cohen, MD

Panelist: Marlene P. Freeman, MD, Laura Fagioli Petrillo, EdM, MD

4:55 – 5:15 PM           Adjourn


SATURDAY, OCTOBER 17, 2026

8:00 – 8:05 AM          Welcoming Remarks & Introduction

Oliver Freudenreich, MD, FACLP

MODULE TOPIC – PSYCHOSIS

8:05 – 8:50 AM           First-Episode Psychosis and Schizophrenia

        Oliver Freudenreich, MD, FACLP

8:50 – 9:35 AM           Management of Side-Effects of Antipsychotics

Abigail Donovan, MD

9:35 – 9:50 AM           Break

MODULE TOPIC – KETAMINE & ESKETAMINE

9:50 – 10:35 AM          Ketamine and Esketamine: From Research to Clinical Practice

Cristina Cusin, MD

10:35 – 11:15 AM       Panel Discussion

Moderator: David Mischoulon, MD

Panelists: Cristina Cusin, MD, Oliver Freudenreich, MD, FACLP, Abigail Donovan, MD

11:15 – 12:15 PM        Lunch Break

MODULE TOPIC – NEW THERAPIES: WHAT IS ON THE HORIZON?

12:15 – 1:00 PM          Neuromodulation and Interventional Psychiatry

Joan Camprodon, MD, MPH

1:00 – 1:45 PM            New Treatments for Schizophrenia

Oliver Freudenreich, MD, FACLP

1:45 – 2:00 PM            Break

2:00 – 2:45 PM            Psychedelics

Franklin King, MD

2:45-3:30 PM             Amplifying and Extending the Effects of Addiction Treatment

John F. Kelly, PhD

3:30 – 4:20 PM           Panel Discussion

Moderator: Oliver Freudenreich, MD, FACLP

Panelists: Franklin King, MD, Joan Camprodon, MD, MPH, John F. Kelly, PhD

4:20 – 4:30 PM            Adjourn


SUNDAY, OCTOBER 18, 2026

7:55- 8:00 AM            Welcoming Remarks & Introduction

David Rubin, MD

MODULE TOPIC – ADDICTION

8:00 – 8:40 AM            Alcohol and Opioids

Vinod Rao, MD, PhD

8:40 – 9:20 AM            Treatment of Tobacco Use Disorders

Anne Eden Evins, MD

9:20 – 9:50 AM            Panel Discussion

Moderator: David Rubin, MD

Panelists: Vinod Rao, MD, PhD, Anne Eden Evins, MD

9:50 – 10:05 AM          Break

MODULE TOPIC – OCD

10:05 – 10:50 AM        Psychopharmacology of OCD

Lisa M. Zakhary, MD, PhD

10:50 – 11:35 AM      Psychopharmacology for Obsessive-Compulsive Related Disorders

Erica Greenberg, MD

11:35 – 12:20 PM        Cognitive Behavioral Therapy, Digital And AI-Powered Interventions for OCD and Related Disorders

Sabine Wilhelm, PhD

12:20 – 12:50 PM        Panel Discussion

Moderator: Sabine Wilhelm, PhD

Panelists: Lisa M. Zakhary, MD, PhD, Erica Greenberg, MD

12:50 – 1:50 PM          Lunch Break

MODULE TOPIC – ACROSS THE LIFESPAN

1:50 – 2:35 PM            Pediatric Bipolar Disorder and Mood Disorders

Mai Uchida, MD

2:35 – 3:20 PM            ADHD

Timothy Wilens, MD

3:20 – 4:05 PM            Drug Interactions

Jonathan E. Alpert, MD, PhD

4:05 – 4:45 PM            Panel Discussion

Moderator: Timothy Wilens, MD

Panelists: Jonathan E. Alpert, MD, Mai Uchida, MD

4:45 PM                      Adjourn

The Westin Copley Place
10 Huntington Avenue
Boston, MA 02116
United States
+1 (617) 262-9600

Join us at the Westin Copley Place for Psychopharmacology 2026

We have arranged a special discounted rate for our valued Psychopharmacology 2026 attendees.
Please book by September 24, 2026 to enjoy this group rate.

https://book.passkey.com/e/51029052

Policy on Faculty and Provider Disclosure:

Disclosure Information
In accordance with the disclosure policy of MGH Institute of Health Professions as well as guidelines set forth by the Accreditation Council on Continuing Medical Education, all people in control of educational content, including speakers, course directors, planners, and reviewers, have been asked to disclose all financial relationships with ineligible companies for the past 24 months, as defined below:

Ineligible Companies 
The ACCME defines an “Ineligible company” as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.” For more information, visit accme.org/standards.

Financial Relationships
Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options, or other ownership interest, excluding diversified mutual funds), or other financial benefit.  Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. 

Mitigation of Financial Relationships
All financial relationships are reviewed to determine which ones are relevant, and then measures are taken to mitigate all relevant financial relationships and ensure that they do not insert commercial bias into the content of the education.


Faculty

Course Directors:

Maurizio Fava, MD
Chair, Mass General Brigham Academic Medical Centers (AMC) Department of Psychiatry
Co-Chair, Mass General Brigham Research Oversight Committee (ROC)
Executive Director, Clinical Trials Network and Institute (CTNI)
Mass General Brigham (MGB)
Slater Family Professor of Psychiatry 
Harvard Medical School 

Jerrold F. Rosenbaum, MD
Psychiatrist-in-Chief Emeritus
Director, Center for the Neuroscience of Psychedelics
Massachusetts General Hospital
Stanley Cobb, Professor of Psychiatry, Harvard Medical School


Speakers:

Jonathan E. Alpert, MD, PhD
Silverman University Chair, Department of Psychiatry and Behavioral Sciences
Professor of Psychiatry, Neuroscience, and Pediatrics
Psychiatrist-in-Chief
Montefiore Medical Center
Albert Einstein College of Medicine

James Barrett, PhD
Director of Clinical Support, Cambridge Police
Assistant Professor of Psychology (part-time)
Harvard Medical School 

Khadijah Booth Watkins, MD, MPH, DFAACAP 
Interim Director, Child and Adolescent Psychiatry Residency Training  
Associate Director, The Clay Center for Young Healthy Minds
Associate Director, Psychiatry Clerkship, Harvard Medical School
Instructor, Harvard Medical School

Frederick Cabral
Superintendent Support Services
Cambridge Police

Joan Camprodon, MD, MPH, PhD
Chief, Division of Neuropsychiatry
Director, Laboratory for Neuropsychiatry & Neuromodulation
Director, Transcranial Magnetic Stimulation (TMS) clinical service
Massachusetts General Hospital
Associate Professor of Psychiatry, Harvard Medical School

Amit Chopra, MBBS, DFAPA
Psychiatrist and Sleep Specialist
Massachusetts General Hospital
Assistant Professor, Harvard Medical School

Jonah Cohen, PhD
Associate Director, Center for Anxiety
and Traumatic Stress Disorders

Lee S. Cohen, MD
Director, Ammon-Pinizzotto Center for Women’s Mental Health
Perinatal and Reproductive Psychiatry Clinical Research Program
Massachusetts General Hospital 
Associate Chief of Psychiatry (Philanthropy and Department Communications)
Edmund and Carroll Carpenter Professor of Psychiatry
Harvard Medical School

Cristina Cusin, MD
Director, Ketamine Clinic and Associate Director, Depression Clinical and Research Program
Massachusetts General Hospital
Associate Professor of Psychiatry
Harvard Medical School

Abigail L. Donovan, MD
Medical Director, Acute Psychiatry Service
Director of Clinical Services, Psychosis Clinical and Research Program
Director, First Episode and Early Psychosis Program
Massachusetts General Hospital

A. Eden Evins, MD, MPH
Cox Family Professor of Psychiatry, Harvard Medical School
Founding Director, Mass General Hospital Center for Addiction Medicine
Director for Faculty Development, Mass General Hospital Department of Psychiatry

Laura Fagioli Petrillo, EdM, MD
Director of Training
The Ammon-Pinizzotto Center for Women’s Mental Health, Massachusetts General Hospital
Instructor in Psychiatry, Harvard Medical School

Maurizio Fava, MD
Chair, Mass General Brigham Academic Medical Centers (AMC) Department of Psychiatry
Co-Chair, Mass General Brigham Research Oversight Committee (ROC)
Executive Director, Clinical Trials Network and Institute (CTNI)
Mass General Brigham (MGB)
Slater Family Professor of Psychiatry 
Harvard Medical School

Marlene  P. Freeman, MD
Professor of Psychiatry, Harvard Medical School
Massachusetts General Hospital Department of Psychiatry
Director of Clinical Services and Associate Director, 
Ammon-Pinizzotto Center for Women’s Mental Health, Perinatal and Reproductive Psychiatry 
Abra Prentice Foundation Chair in Women’s Mental Health
Medical Director, MGH Clinical Trials Network and Institute
Editor in Chief, The Journal of Clinical Psychiatry

Oliver Freudenreich, MD, FACLP
Professor of Clinical Psychiatry
Harvard Medical School
Co-Director, MGH Psychosis Clinical and Research Program
Massachusetts General Hospital 

Jennifer R. Gatchel, MD, PhD
Assistant Psychiatrist, Massachusetts General Hospital/McLean Hospital
Partners Geriatric Psychiatry Fellowship, MGH Site Director
Assistant Professor of Psychiatry, Harvard Medical School

Jodi M. Gilman, PhD
Director of Neuroscience, MGH Center for Addiction Medicine 
Director, MGH Graduate Student and Postdoctoral Division
Associate Professor, Harvard Medical School
Department of Psychiatry

Erica Greenberg, MD
Director, Pediatric Psychiatry OCD and Tic Disorders Program
MassGeneral Brigham, Massachusetts General Hospital
Assistant Professor of Psychiatry, Harvard Medical School

Daphne Holt, MD, PhD
Director, Resilience and Prevention Program, MGH Department of Psychiatry
Co-Director, Psychosis Research and Clinical Program, MGH Department of Psychiatry
Associate Professor, Harvard Medical School

Gagan Joshi, MD
Director, The Alan & Lorraine Bressler Clinical and Research Program for Autism Spectrum Disorder
David and Joanne Rovee Chair in Child Psychiatry
Massachusetts General Hospital
Associate Professor of Psychiatry
Harvard Medical School

John F. Kelly, PhD, ABPP
Chief, Division of Addiction Treatment and Prevention, Mass General Brigham AMC, Dept of Psychiatry
Elizabeth R. Spallin, Professor of Psychiatry, Harvard Medical School
Founder and Director, MGH Recovery Research Institute
Founder and Director, National Center on Youth Prevention, Treatment, and Recovery
President, American Board of Addiction Psychology
Board Certified Addiction Psychologist 

Franklin King IV, MD
Franklin King, MD
Director of Training and Education, MGH Center for Neuroscience of Psychedelics
Instructor, Harvard Medical School

Christopher J. McDougle, MD
Director, Lurie Center for Autism
Massachusetts General Hospital 
Nancy Lurie Marks Professor of Psychiatry
Harvard Medical School

David Mischoulon, MD, PhD
Director, Depression Clinical and Research Program
Mass General Brigham Academic Medical Center's Psychiatry Department
Joyce R Tedlow, Professor of Psychiatry, Harvard Medical School

Andrew A. Nierenberg, MD
Thomas P. Hackett, MD, Endowed Chair in Psychiatry at MGH
Director, Dauten Family Center for Bipolar Treatment Innovation
Co-Director, Center for Clinical Research Education, Division of Clinical Research
Massachusetts General Hospital
Professor of Psychiatry, Harvard Medical School

Maren Nyer, PhD
Clinical Psychologist & Director of Yoga Research, Massachusetts General Hospital
Depression Clinical and Research Program (DCRP); Assistant Professor
Harvard Medical School

Roy H. Perlis, MD, MSc
Associate Chief (Research), Department of Psychiatry
Director, Center for Quantitative Health
Ronald I. Dozoretz, MD Endowed Chair
Massachusetts General Hospital
Professor of Psychiatry
Harvard Medical School
Affiliate Faculty
Center for Genomic Medicine, Harvard Stem Cell Institute
Broad Institute of MIT and Harvard

Vinod Rao, MD, PhD
Medical Director, MGH West End Clinic
Chief, MGB Psychiatry Division of Adult Outpatient Psychiatry

Jerrold F. Rosenbaum, MD
Psychiatrist-in-Chief Emeritus
Director, Center for the Neuroscience of Psychedelics
Massachusetts General Hospital
Stanley Cobb, Professor of Psychiatry, Harvard Medical School

David H. Rubin, MD
Director, Division of Professional and Public Education, MGH
Executive Director, MGH Psychiatry Academy and MGH Visiting, MGH
Assistant Professor, Harvard Medical School

Meaghan Rudolph, MS, RN, PMHCNS-BC
Psychiatric Clinical Nurse Specialist, MGH Department of Psychiatry
Instructor, MGH Institute of Health Professions

Theodore A. Stern, MD
Chief Emeritus, Avery D. Weisman Psychiatric Consultation Service,
Director, Thomas P. Hackett Center for Scholarship in Psychosomatic Medicine  
Massachusetts General Hospital;
Ned H. Cassem, Professor of Psychiatry in the field of 
Psychosomatic Medicine/Consultation, 
Harvard Medical School
Editor-in-Chief Emeritus, Psychosomatics/JACLP

Kaloyan Tanev,  MD, MPH
Chief Medical Officer, The Home Base Program
Chief Scientific Officer, The Home Base Program
Inaugural Thomas C. Werner Endowed Chair for Military Health
Medical Director, MGH TBI Clinical and Research Program
Director of Clinical Neuropsychiatry Research, MGH
Associate  Professor in Psychiatry, Harvard Medical School

Mai Uchida, MD
Associate Professor, Department of Psychiatry, Harvard Medical School
Director of Pediatric Depression/ Director of Global Advocacy
Division of Child and Adolescent Psychiatry
Massachusetts General Hospital

Timothy E. Wilens, MD
Chief, Division of Child and Adolescent Psychiatry,
Massachusetts General Hospital/Brigham and Women's Hospital
Professor of Psychiatry,
Harvard Medical School
President-Elect, American Academy of Child and Adolescent Psychiatry

Sabine Wilhelm, PhD
Chief of Psychology, Mass General Brigham (MGB), Psychiatry Department
Director, Center for Digital Mental Health, Massachusetts General Hospital (MGH)
Director, Center for OCD and Related Disorders, MGH
Donovan-Chien Family Endowed Professor in Psychology at Harvard Medical School

John W. Winkelman, MD, PhD
Chief, Sleep Disorders Clinical Research Program 
Departments of Psychiatry and Neurology
Massachusetts General Hospital Professor of Psychiatry
Harvard Medical School

Lisa M. Zakhary, MD, PhD
Medical Director, Center for OCD and Related Disorders
Medical Director, Primary Care Psychiatry
Director of Psychopharmacology, Excoriation Clinic and Research Unit
Massachusetts General Hospital
Assistant Professor, Harvard Medical School

Accreditation pending - please check back for more information.

Price

Cost:
$830.00
Please login or register to take this course.

NOTE: Thursday ticketed events, and Friday and Saturday evening seminars are NOT included in the virtual registration option. These sessions will NOT be live-streamed.